Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

40.01 +2.09 (+5.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harrow, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Harrow Provides TRIESENCE® Relaunch Update
From Harrow, Inc.
Via Business Wire
The Top 7 Growth Stocks to Buy and Hold Until 2030
These seven growth stocks look poised to outperform through 2030 and beyond with market-beating upside potential. 
Via InvestorPlace
Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
From Melt Pharmaceuticals, Inc.
Via Business Wire
Insiders Buying Greenwich LifeSciences And 2 Other Stocks
Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades. 
Via Benzinga
Harrow: Q4 Earnings Insights
 
Via Benzinga
Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study
From Harrow, Inc.
Via Business Wire
3 Stocks Insiders are Buying That Should be on Your Radar
Unusual insider activity indicates opportunities in these stocks positioned to deliver value for shareholders this year. 
Via MarketBeat
Harrow to Present at Two Investor Conferences in May
From Harrow, Inc.
Via Business Wire
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024
HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Harrow Announces First Quarter 2024 Financial Results
From Harrow, Inc.
Via Business Wire
Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial
From Harrow, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
From Harrow, Inc.
Via Business Wire
Around $2M Bet On This Industrial Stock? Check Out These 3 Stocks Insiders Are Buying
 
Via Benzinga
Over $24M Bet On RXO? Check Out These 3 Stocks Insiders Are Buying
 
Via Benzinga
Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
From Melt Pharmaceuticals, Inc.
Via Business Wire
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and... 
Via Benzinga
INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost
Intel stock is rising on Wednesday as investors in INTC shares react to the semiconductor company securing $8.5 billion in funding. 
Via InvestorPlace
Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today?
Aquestive Therapeutics stock is falling on Wednesday after the company price a public offering for AQST shares this morning. 
Via InvestorPlace
Why Is Harrow (HROW) Stock Up 5% Today?
Harrow stock is up on Wednesday as investors in HROW shares react to the company's earnings report for the fourth quarter of 2023! 
Via InvestorPlace
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out as we dive into all of the biggest movements worth reading about on Wednesday morning! 
Via InvestorPlace
Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday. 
Via Benzinga
Topics Stocks
HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023
HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
From Harrow, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.